Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease
Open Access
- 1 September 2004
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 127 (3), 777-791
- https://doi.org/10.1053/j.gastro.2004.06.049
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- GI clinical research 2002–2003: the year in reviewClinical Gastroenterology and Hepatology, 2003
- Increased Enterocyte Apoptosis in Inflamed Areas of Crohn's DiseaseDiseases of the Colon & Rectum, 2003
- A novel PPARγ gene therapy to control inflammation associated with inflammatory bowel disease in a murine modelGastroenterology, 2003
- Loss of the Peroxisome Proliferation-activated Receptor gamma (PPARγ) Does Not Affect Mammary Development and Propensity for Tumor Formation but Leads to Reduced FertilityPublished by Elsevier BV ,2002
- Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPARγ-dependent mechanismBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2002
- The Immunology of Mucosal Models of InflammationAnnual Review of Immunology, 2002
- Critical roles of PPARβ/δ in keratinocyte response to inflammationGenes & Development, 2001
- Conjugated linoleic acid activates peroxisome proliferator-activated receptor α and β subtypes but does not induce hepatic peroxisome proliferation in Sprague–Dawley ratsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994